Avalon researchers published important research on distinguishing between viral and bacterial respiratory infections, a topic that is of great importance given the COVID-19 pandemic. Check out the study at: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1736872
read moreWithin a few months we’ve gone from worrying about holiday shopping to worrying about global pandemics and watching the world shut down around us. It started with news from China on the rapid spread of an insidious virus initially called a coronavirus.[1] Once the virus was better understood it became known as COVID-19. The disease…
read moreA common challenge in economics and business is determining the fair-market value of products and services that have not yet “entered” the market. If consumers have not yet signaled a “willingness to pay” for the product or service, it is difficult to predict the fair market value. However, for products and services that fairly well defined,…
read moreIn recent years in the U.S., there has been an increase in the use of cost-effectiveness analysis (CEA) for drug and medical device coverage decisions. While the Center for Medicare and Medicaid Services (CMS) remains considerably behind European countries in the use of CEA in health technology assessment (HTA),1 private health insurers have begun to…
read moreAvalon Health Economics will be at ISPOR Copenhagen November 2nd-6th. Let us know if you will be there and want to set up a meeting! For more information, please visit the ISPOR website.
read moreEconomic evaluation of passive monitoring technology for seniors 2019 By John E. Schneider, Jacie Cooper. Cara Scheibling, and Anjani Parikh Abstract: By 2050, the global population of persons over the age of 60 is expected to be between 1.5 and 2 billion [1, 2]. Moreover, the proportion of individuals over the age of 80 is simultaneously and…
read moreAvalon Health Economics has entered into a collaborative agreement with Oberender, a leading global healthcare management consultancy based in Germany. The agreement allows Avalon and Oberender to collaborate in a variety of ways, offering Avalon’s U.S. clients access to European market access, technology assessment, and management consulting, and offering Oberender added reach into…
read moreAdvances in technological innovation and access to capital have recently resulted in a wave of new medical devices, including more accurate diagnostic tools, remote monitoring systems, and automated surgical tools. This next generation of medical devices has the potential to lower costs and improve outcomes. Perceptive device makers are taking the time to carefully develop…
read moreThis research summary is written by John E. Schneider, PhD & Cara M. Scheibling A two-decade drumbeat of bold, future-focused and entirely bi-partisan changes in U.S. state laws has ushered in the modern practice of optometry. The result has been a dramatic expansion of the profession’s independent physician role in health care coupled with…
read moreRecently, the crypto-currency company Bitcoin has been in the news, mainly for its combination of volatility in valuation coupled with its impenetrable technological foundation. The virtual currency is perhaps the most well-known application of a technology now commonly referred to as “blockchain.”[1] Each time those Bitcoin stories run, many of us again ask ourselves “what…
read more